Lazard Asset Management’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $620K | Buy |
284,498
+137,983
| +94% | +$301K | ﹤0.01% | 1440 |
|
|
2025
Q1 | $399K | Sell |
146,515
-16,980
| -10% | -$46.2K | ﹤0.01% | 1467 |
|
|
2024
Q4 | $680K | Sell |
163,495
-197,955
| -55% | -$823K | ﹤0.01% | 1280 |
|
|
2024
Q3 | $1.41M | Sell |
361,450
-51,448
| -12% | -$200K | ﹤0.01% | 966 |
|
|
2024
Q2 | $1.62M | Sell |
412,898
-54,789
| -12% | -$215K | ﹤0.01% | 885 |
|
|
2024
Q1 | $1.96M | Buy |
467,687
+100,555
| +27% | +$421K | ﹤0.01% | 830 |
|
|
2023
Q4 | $1.73M | Sell |
367,132
-90,236
| -20% | -$424K | ﹤0.01% | 875 |
|
|
2023
Q3 | $1.43M | Sell |
457,368
-13,084
| -3% | -$40.8K | ﹤0.01% | 916 |
|
|
2023
Q2 | $2.16M | Buy |
470,452
+3,322
| +0.7% | +$15.2K | ﹤0.01% | 879 |
|
|
2023
Q1 | $2.31M | Buy |
467,130
+110,069
| +31% | +$545K | ﹤0.01% | 890 |
|
|
2022
Q4 | $1.95M | Sell |
357,061
-128,043
| -26% | -$699K | ﹤0.01% | 908 |
|
|
2022
Q3 | $3.15M | Buy |
485,104
+18,503
| +4% | +$120K | ﹤0.01% | 798 |
|
|
2022
Q2 | $2.21M | Buy |
+466,601
| New | +$2.21M | ﹤0.01% | 883 |
|